(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FADS2 mRNA] CTD PMID:31150632 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression ISO RGD:68475 6480464 o, p'-DDT results in decreased expression of FADS2 mRNA CTD PMID:18204070 1,1-dichloroethene decreases expression ISO RGD:68476 6480464 vinylidene chloride results in decreased expression of FADS2 mRNA CTD PMID:26682919 1,2-dichloroethane decreases expression ISO RGD:68476 6480464 ethylene dichloride results in decreased expression of FADS2 mRNA CTD PMID:28189721 , PMID:28960355 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of FADS2 mRNA CTD PMID:30723492 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of FADS2 mRNA CTD PMID:17108234 17beta-estradiol affects expression ISO RGD:68475 6480464 Estradiol affects the expression of FADS2 mRNA CTD PMID:22574217 17beta-estradiol multiple interactions ISO RGD:68475 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of FADS2 mRNA CTD PMID:20823114 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:68476 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:68476 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of FADS2 mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to FADS2 gene] CTD PMID:16214954 , PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:68475 6480464 Tetrachlorodibenzodioxin results in decreased expression of FADS2 mRNA CTD PMID:21998131 , PMID:26238291 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:68476 6480464 Tetrachlorodibenzodioxin results in decreased expression of FADS2 mRNA CTD PMID:18796159 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:68476 6480464 Tetrachlorodibenzodioxin affects the expression of FADS2 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FADS2 mRNA CTD PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of FADS2 mRNA CTD PMID:21215274 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of FADS2 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of FADS2 mRNA CTD PMID:21346803 2-butoxyethanol increases expression ISO RGD:68476 6480464 n-butoxyethanol results in increased expression of FADS2 mRNA CTD PMID:19812364 3,3',5-triiodo-L-thyronine increases expression EXP 6480464 Triiodothyronine results in increased expression of FADS2 mRNA CTD PMID:15953391 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:68475 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FADS2 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:68475 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FADS2 protein CTD PMID:34186270 4-hydroxyphenyl retinamide increases expression ISO RGD:68476 6480464 Fenretinide results in increased expression of FADS2 mRNA CTD PMID:28973697 5-azacytidine decreases expression ISO RGD:68475 6480464 Azacitidine results in decreased expression of FADS2 mRNA CTD PMID:20823114 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of FADS2 mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of FADS2 mRNA CTD PMID:19483382 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of FADS2 mRNA CTD PMID:24780913 , PMID:25825206 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of FADS2 mRNA CTD PMID:31881176 acrylamide decreases expression ISO RGD:68475 6480464 Acrylamide results in decreased expression of FADS2 mRNA CTD PMID:32763439 aflatoxin B1 decreases expression ISO RGD:68476 6480464 Aflatoxin B1 results in decreased expression of FADS2 mRNA CTD PMID:19770486 aflatoxin B1 affects methylation ISO RGD:68475 6480464 Aflatoxin B1 affects the methylation of FADS2 intron CTD PMID:30157460 aflatoxin B1 decreases expression ISO RGD:68475 6480464 Aflatoxin B1 results in decreased expression of FADS2 mRNA CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:68475 6480464 Tretinoin results in increased expression of FADS2 mRNA CTD PMID:33167477 amiodarone multiple interactions ISO RGD:68475 6480464 [2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Amiodarone results in increased expression of FADS2 mRNA] more ... CTD PMID:21123845 amiodarone affects expression ISO RGD:68475 6480464 Amiodarone affects the expression of FADS2 mRNA CTD PMID:29248575 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of FADS2 mRNA CTD PMID:19483382 amiodarone increases expression ISO RGD:68475 6480464 Amiodarone results in increased expression of FADS2 mRNA CTD PMID:21123845 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of FADS2 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:68475 6480464 Antirheumatic Agents results in decreased expression of FADS2 mRNA CTD PMID:24449571 arachidonic acid decreases expression ISO RGD:68475 6480464 Arachidonic Acid results in decreased expression of FADS2 mRNA CTD PMID:21457203 arsane decreases expression EXP 6480464 Arsenic results in decreased expression of FADS2 mRNA CTD PMID:18315880 arsenic atom decreases expression EXP 6480464 Arsenic results in decreased expression of FADS2 mRNA CTD PMID:18315880 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of FADS2 mRNA CTD PMID:19483382 benzo[a]pyrene decreases expression ISO RGD:68476 6480464 Benzo(a)pyrene results in decreased expression of FADS2 mRNA CTD PMID:19770486 benzo[a]pyrene increases methylation ISO RGD:68475 6480464 Benzo(a)pyrene results in increased methylation of FADS2 5' UTR, Benzo(a)pyrene results in increased methylation of FADS2 exon CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:68475 6480464 Benzo(a)pyrene affects the methylation of FADS2 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:68475 6480464 Benzo(a)pyrene results in decreased expression of FADS2 mRNA CTD PMID:26238291 benzo[a]pyrene diol epoxide I increases expression ISO RGD:68475 6480464 7 more ... CTD PMID:20382639 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of FADS2 mRNA CTD PMID:17630414 bexarotene multiple interactions EXP 6480464 [Tamoxifen co-treated with bexarotene] results in increased expression of FADS2 mRNA CTD PMID:17630414 bezafibrate increases activity EXP 6480464 Bezafibrate results in increased activity of FADS2 protein CTD PMID:7606338 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:68476 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of FADS2 mRNA] CTD PMID:19850644 bis(2-ethylhexyl) phthalate increases expression ISO RGD:68476 6480464 Diethylhexyl Phthalate results in increased expression of FADS2 mRNA CTD PMID:19245819 , PMID:19850644 bisphenol A increases expression ISO RGD:68476 6480464 bisphenol A results in increased expression of FADS2 mRNA CTD PMID:25270620 bisphenol A affects expression ISO RGD:68476 6480464 bisphenol A affects the expression of FADS2 mRNA CTD PMID:35341816 bisphenol A decreases expression ISO RGD:68476 6480464 bisphenol A results in decreased expression of FADS2 mRNA CTD PMID:33221593 bisphenol A affects expression ISO RGD:68475 6480464 bisphenol A affects the expression of FADS2 mRNA CTD PMID:30903817 bisphenol A increases expression ISO RGD:68475 6480464 bisphenol A results in increased expression of FADS2 mRNA, bisphenol A results in increased expression of FADS2 protein CTD PMID:29275510 , PMID:34186270 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of FADS2 mRNA CTD PMID:30903817 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of FADS2 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FADS2 mRNA CTD PMID:25181051 more ... bisphenol F multiple interactions ISO RGD:68475 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FADS2 mRNA CTD PMID:28628672 bortezomib decreases expression ISO RGD:68475 6480464 Bortezomib results in decreased expression of FADS2 mRNA CTD PMID:20977926 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of FADS2 mRNA CTD PMID:32479839 bucladesine multiple interactions ISO RGD:68475 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of FADS2 mRNA CTD PMID:20823114 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of FADS2 mRNA CTD PMID:24136188 butanal decreases expression ISO RGD:68475 6480464 butyraldehyde results in decreased expression of FADS2 mRNA CTD PMID:26079696 cadmium dichloride decreases expression ISO RGD:68476 6480464 Cadmium Chloride results in decreased expression of FADS2 mRNA CTD PMID:24982889 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of FADS2 mRNA CTD PMID:25993096 carbamazepine decreases expression ISO RGD:68475 6480464 Carbamazepine results in decreased expression of FADS2 mRNA CTD PMID:21123845 carbon nanotube decreases expression ISO RGD:68476 6480464 Nanotubes more ... CTD PMID:25620056 chlordecone increases expression ISO RGD:68476 6480464 Chlordecone results in increased expression of FADS2 mRNA CTD PMID:33711761 chloroquine decreases expression EXP 6480464 Chloroquine results in decreased expression of FADS2 mRNA CTD PMID:19393257 choline multiple interactions ISO RGD:68476 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FADS2 gene CTD PMID:20938992 chrysin decreases expression ISO RGD:68475 6480464 chrysin results in decreased expression of FADS2 mRNA CTD PMID:20816778 cisplatin increases expression ISO RGD:68475 6480464 Cisplatin results in increased expression of FADS2 mRNA CTD PMID:27594783 cisplatin multiple interactions ISO RGD:68475 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of FADS2 mRNA CTD PMID:27392435 clobetasol increases expression ISO RGD:68476 6480464 Clobetasol results in increased expression of FADS2 mRNA CTD PMID:27462272 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of FADS2 mRNA CTD PMID:19483382 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of FADS2 mRNA CTD PMID:12851107 , PMID:33983380 clofibrate increases activity EXP 6480464 Clofibrate results in increased activity of FADS2 protein CTD PMID:7606338 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of FADS2 protein CTD PMID:6821269 cobalt dichloride decreases expression ISO RGD:68475 6480464 cobaltous chloride results in decreased expression of FADS2 mRNA CTD PMID:19320972 , PMID:19376846 copper atom decreases expression EXP 6480464 Copper results in decreased expression of FADS2 mRNA CTD PMID:22465980 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of FADS2 mRNA CTD PMID:22465980 crizotinib increases expression ISO RGD:68475 6480464 crizotinib results in increased expression of FADS2 mRNA CTD PMID:23707608 curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of FADS2 mRNA CTD PMID:27208389 curcumin affects expression ISO RGD:68476 6480464 Curcumin affects the expression of FADS2 mRNA CTD PMID:27208389 cyanocob(III)alamin multiple interactions EXP 6480464 [Vitamin B 12 deficiency co-treated with Fatty Acids more ... CTD PMID:22133376 dexamethasone multiple interactions ISO RGD:68475 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FADS2 mRNA CTD PMID:28628672 dextran sulfate decreases expression ISO RGD:68476 6480464 Dextran Sulfate results in decreased expression of FADS2 mRNA CTD PMID:35093514 Di-n-hexyl phthalate decreases expression ISO RGD:68475 6480464 di-n-hexyl phthalate results in decreased expression of FADS2 mRNA CTD PMID:33043605 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of FADS2 mRNA CTD PMID:21266533 dipentyl phthalate increases expression EXP 6480464 di-n-pentyl phthalate results in increased expression of FADS2 mRNA CTD PMID:33983380 diuron increases expression EXP 6480464 Diuron results in increased expression of FADS2 mRNA CTD PMID:21551480 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of FADS2 mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO RGD:68476 6480464 epoxiconazole results in decreased expression of FADS2 mRNA CTD PMID:35436446 ethanol increases expression ISO RGD:68476 6480464 Ethanol results in increased expression of FADS2 mRNA CTD PMID:19167417 , PMID:30319688 ethanol multiple interactions ISO RGD:68476 6480464 Ethanol affects the expression of and affects the splicing of FADS2 mRNA CTD PMID:30319688 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of FADS2 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:68476 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FADS2 gene CTD PMID:20938992 folic acid increases expression ISO RGD:68476 6480464 Folic Acid results in increased expression of FADS2 mRNA CTD PMID:25629700 folic acid multiple interactions EXP 6480464 [Vitamin B 12 deficiency co-treated with Folic Acid] results in decreased activity of FADS2 protein more ... CTD PMID:22133376 folic acid decreases activity EXP 6480464 Folic Acid results in decreased activity of FADS2 protein CTD PMID:22133376 Ganoderic acid A multiple interactions ISO RGD:68476 6480464 [Dietary Fats co-treated with ganoderic acid A] affects the expression of FADS2 mRNA CTD PMID:29852127 Ganoderic acid A decreases expression ISO RGD:68475 6480464 ganoderic acid A results in decreased expression of FADS2 mRNA CTD PMID:29852127 gemfibrozil increases activity EXP 6480464 Gemfibrozil results in increased activity of FADS2 protein CTD PMID:7606338 genistein decreases expression ISO RGD:68475 6480464 Genistein results in decreased expression of FADS2 mRNA CTD PMID:20816778 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of FADS2 mRNA CTD PMID:33387578 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of FADS2 mRNA CTD PMID:24136188 indinavir multiple interactions ISO RGD:68476 6480464 [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of FADS2 mRNA CTD PMID:16931933 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of FADS2 mRNA CTD PMID:21396975 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FADS2 mRNA CTD PMID:22129741 indometacin multiple interactions ISO RGD:68475 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FADS2 mRNA CTD PMID:28628672 isoflavones increases expression ISO RGD:68475 6480464 Isoflavones results in increased expression of FADS2 mRNA CTD PMID:17374662 isotretinoin decreases expression ISO RGD:68475 6480464 Isotretinoin results in decreased expression of FADS2 mRNA CTD PMID:20436886 ivermectin decreases expression ISO RGD:68475 6480464 Ivermectin results in decreased expression of FADS2 protein CTD PMID:32959892 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of FADS2 mRNA CTD PMID:19483382 L-methionine multiple interactions ISO RGD:68476 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FADS2 gene CTD PMID:20938992 lamivudine multiple interactions ISO RGD:68476 6480464 [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of FADS2 mRNA, [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of FADS2 mRNA CTD PMID:16931933 linoleic acid multiple interactions ISO RGD:68475 6480464 [Linoleic Acid co-treated with Testosterone] results in increased expression of FADS2 mRNA CTD PMID:21457203 linoleic acid multiple interactions ISO RGD:68476 6480464 FADS2 protein inhibits the reaction [Linoleic Acid results in increased activity of LOX protein] CTD PMID:26240151 linoleic acid increases expression ISO RGD:68475 6480464 Linoleic Acid results in increased expression of FADS2 mRNA, Linoleic Acid results in increased expression of FADS2 protein CTD PMID:21457203 lithocholic acid decreases expression ISO RGD:68476 6480464 Lithocholic Acid results in decreased expression of FADS2 mRNA CTD PMID:20359477 lovastatin multiple interactions ISO RGD:68476 6480464 [Dietary Fats co-treated with Lovastatin] affects the expression of FADS2 mRNA CTD PMID:29852127 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of FADS2 mRNA CTD PMID:28801915 medroxyprogesterone acetate multiple interactions ISO RGD:68475 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of FADS2 mRNA CTD PMID:20823114 methidathion decreases expression ISO RGD:68476 6480464 methidathion results in decreased expression of FADS2 mRNA CTD PMID:34813904 methotrexate affects response to substance ISO RGD:68475 6480464 FADS2 protein affects the susceptibility to Methotrexate CTD PMID:16217747 methyl methanesulfonate decreases expression ISO RGD:68475 6480464 Methyl Methanesulfonate results in decreased expression of FADS2 mRNA CTD PMID:23649840 miconazole increases expression ISO RGD:68476 6480464 Miconazole results in increased expression of FADS2 mRNA CTD PMID:27462272 microcystin-LR decreases expression ISO RGD:68476 6480464 cyanoginosin LR results in decreased expression of FADS2 protein CTD PMID:26984711 monosodium L-glutamate increases expression ISO RGD:68476 6480464 Sodium Glutamate results in increased expression of FADS2 mRNA CTD PMID:19001666 N-acetyl-L-cysteine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FADS2 mRNA CTD PMID:22129741 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of FADS2 mRNA CTD PMID:28801915 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of FADS2 mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FADS2 mRNA CTD PMID:22129741 N-nitrosodiethylamine increases expression ISO RGD:68476 6480464 Diethylnitrosamine results in increased expression of FADS2 mRNA CTD PMID:24535843 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of FADS2 mRNA CTD PMID:24136188 nickel atom decreases expression ISO RGD:68475 6480464 Nickel results in decreased expression of FADS2 mRNA CTD PMID:24768652 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of FADS2 mRNA CTD PMID:24136188 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of FADS2 mRNA CTD PMID:19483382 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of FADS2 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of FADS2 mRNA CTD PMID:25729387 paliperidone palmitate increases expression EXP 6480464 Paliperidone Palmitate results in increased expression of FADS2 mRNA CTD PMID:21458237 paliperidone palmitate multiple interactions EXP 6480464 [Paliperidone Palmitate results in increased expression of FADS2 mRNA] which results in increased abundance of Fatty Acids, Unsaturated CTD PMID:21458237 paracetamol decreases expression ISO RGD:68475 6480464 Acetaminophen results in decreased expression of FADS2 mRNA CTD PMID:21420995 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of FADS2 mRNA CTD PMID:33387578 paraquat decreases expression ISO RGD:68476 6480464 Paraquat results in decreased expression of FADS2 mRNA CTD PMID:21371552 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of FADS2 mRNA CTD PMID:18692542 perfluorooctanoic acid decreases expression ISO RGD:68475 6480464 perfluorooctanoic acid results in decreased expression of FADS2 protein CTD PMID:26879310 perfluorooctanoic acid affects expression ISO RGD:68475 6480464 perfluorooctanoic acid affects the expression of FADS2 mRNA CTD PMID:32068100 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of FADS2 protein CTD PMID:34958885 phenethyl isothiocyanate decreases expression ISO RGD:68475 6480464 phenethyl isothiocyanate results in decreased expression of FADS2 mRNA CTD PMID:26678675 phenobarbital affects expression ISO RGD:68476 6480464 Phenobarbital affects the expression of FADS2 mRNA CTD PMID:19136022 phytosterols multiple interactions ISO RGD:68476 6480464 APOE gene mutant form affects the reaction [Phytosterols results in increased expression of FADS2 mRNA] CTD PMID:18155511 pirinixic acid affects expression ISO RGD:68476 6480464 pirinixic acid affects the expression of FADS2 mRNA CTD PMID:19136022 pirinixic acid increases expression ISO RGD:68476 6480464 pirinixic acid results in increased expression of FADS2 mRNA CTD PMID:16357043 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of FADS2 mRNA CTD PMID:15654130 more ... pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of FADS2 mRNA CTD PMID:19483382 potassium chromate increases expression ISO RGD:68475 6480464 potassium chromate(VI) results in increased expression of FADS2 mRNA CTD PMID:22714537 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:68476 6480464 Pregnenolone Carbonitrile results in decreased expression of FADS2 mRNA CTD PMID:28903501 progesterone increases expression ISO RGD:68475 6480464 Progesterone results in increased expression of FADS2 mRNA CTD PMID:18070364 risperidone multiple interactions EXP 6480464 [Risperidone results in increased expression of FADS2 mRNA] which results in increased abundance of Fatty Acids, Unsaturated CTD PMID:21458237 risperidone increases expression EXP 6480464 Risperidone results in increased expression of FADS2 mRNA CTD PMID:21458237 rotenone affects expression EXP 6480464 Rotenone affects the expression of FADS2 mRNA CTD PMID:28374803 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of FADS2 mRNA CTD PMID:28374803 saquinavir multiple interactions ISO RGD:68476 6480464 [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of FADS2 mRNA CTD PMID:16931933 sevoflurane affects expression EXP 6480464 sevoflurane affects the expression of FADS2 mRNA CTD PMID:15967596 silicon dioxide decreases expression ISO RGD:68475 6480464 Silicon Dioxide analog results in decreased expression of FADS2 mRNA CTD PMID:25895662 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of FADS2 mRNA CTD PMID:25993096 sodium fluoride decreases expression ISO RGD:68476 6480464 Sodium Fluoride results in decreased expression of FADS2 protein CTD PMID:28918527 sunitinib increases expression ISO RGD:68475 6480464 Sunitinib results in increased expression of FADS2 mRNA CTD PMID:23707608 , PMID:31533062 tamoxifen decreases expression ISO RGD:68476 6480464 Tamoxifen results in decreased expression of FADS2 mRNA CTD PMID:25123088 tamoxifen multiple interactions EXP 6480464 [Tamoxifen co-treated with bexarotene] results in increased expression of FADS2 mRNA CTD PMID:17630414 tamoxifen decreases expression EXP 6480464 Tamoxifen results in decreased expression of FADS2 mRNA CTD PMID:17630414 , PMID:28138993 testosterone multiple interactions ISO RGD:68475 6480464 [Linoleic Acid co-treated with Testosterone] results in increased expression of FADS2 mRNA CTD PMID:21457203 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of FADS2 mRNA CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:68476 6480464 Carbon Tetrachloride results in decreased expression of FADS2 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FADS2 mRNA] CTD PMID:31150632 thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of FADS2 protein CTD PMID:35544339 thimerosal decreases expression ISO RGD:68475 6480464 Thimerosal results in decreased expression of FADS2 mRNA CTD PMID:27188386 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of FADS2 mRNA CTD PMID:19483382 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of FADS2 mRNA CTD PMID:34492290 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of FADS2 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of FADS2 mRNA CTD PMID:25729387 trichloroethene increases expression ISO RGD:68476 6480464 Trichloroethylene results in increased expression of FADS2 mRNA CTD PMID:25549359 trichostatin A decreases expression ISO RGD:68475 6480464 trichostatin A results in decreased expression of FADS2 mRNA CTD PMID:27188386 Triptolide decreases expression ISO RGD:68476 6480464 triptolide results in decreased expression of FADS2 mRNA CTD PMID:32835833 troglitazone multiple interactions EXP 6480464 troglitazone inhibits the reaction [Dietary Sucrose results in increased activity of FADS2 protein], troglitazone inhibits the reaction [Dietary Sucrose results in increased expression of FADS2 mRNA] CTD PMID:15763435 troglitazone decreases expression ISO RGD:68476 6480464 troglitazone results in decreased expression of FADS2 mRNA CTD PMID:28973697 troglitazone multiple interactions ISO RGD:68475 6480464 [troglitazone results in decreased expression of FADS2 mRNA] which affects the abundance of Cholesterol Esters more ... CTD PMID:11916926 troglitazone decreases expression ISO RGD:68475 6480464 troglitazone results in decreased expression of FADS2 mRNA CTD PMID:11916926 urethane decreases expression ISO RGD:68475 6480464 Urethane results in decreased expression of FADS2 mRNA CTD PMID:28818685 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of FADS2 mRNA CTD PMID:24136188 valproic acid decreases expression ISO RGD:68476 6480464 Valproic Acid results in decreased expression of FADS2 mRNA CTD PMID:21427059 valproic acid decreases expression ISO RGD:68475 6480464 Valproic Acid results in decreased expression of FADS2 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:68475 6480464 Valproic Acid affects the expression of FADS2 mRNA CTD PMID:25979313 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of FADS2 mRNA CTD PMID:22570695 vorinostat decreases expression ISO RGD:68475 6480464 vorinostat results in decreased expression of FADS2 mRNA CTD PMID:27188386 Yessotoxin increases expression ISO RGD:68475 6480464 yessotoxin analog results in increased expression of FADS2 mRNA CTD PMID:30679557 zidovudine multiple interactions ISO RGD:68476 6480464 [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of FADS2 mRNA, [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of FADS2 mRNA CTD PMID:16931933 zoledronic acid increases expression ISO RGD:68475 6480464 zoledronic acid results in increased expression of FADS2 mRNA CTD PMID:24714768